First Myeloma Patient Treated with CAR-T Successfully Discharged
SHANGHAI, Jan. 23, 2024 /PRNewswire/ — In another milestone since the implementation of CAR-T therapy at Jiahui, the first myeloma patient treated with CAR-T at Jiahui International Hospital was recently discharged two weeks after infusion. The foreign patient was first diagnosed with multiple
Kansas City Life Declares Quarterly Dividend
KANSAS CITY, Mo., Jan. 22, 2024 /PRNewswire/ — The Board of Directors of Kansas City Life Insurance Company declared a quarterly dividend of $0.14 per share on Jan. 22, 2024. The dividend will be payable on Feb. 7, 2024, to stockholders of record on Feb. 1, 2024. Kansas City Life Insurance Co
Ability™ Secures Gold at Brandon Hall’s Excellence in Technology Awards
The Competency Alliance’s Premier Platform and Competency Engine Receives Top Honors for Advancing Career and Competency Management Technology HOUSTON, Jan. 22, 2024 /PRNewswire/ — The Competency Alliance (TCA), a leader in innovative learning and development solutions, has been awarded
Taiwan Expands Investment to Enhance International Collaboration Initiatives, Empowering Taiwanese Content and Talent to Thrive in the Global Market
TAIPEI, Jan. 23, 2024 /PRNewswire/ — To aggregate an increased volume of Taiwanese content for global audiences and foster collaboration opportunities between Taiwan and the international community, Taiwan Creative Content Agency (TAICCA) has officially launched “Taiwan’s Internati
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of agilon health, inc. – AGL
NEW YORK, Jan. 22, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of agilon health, inc. (“Agilon Health” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980,
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Xponential Fitness, Inc. – XPOF
NEW YORK, Jan. 22, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Xponential Fitness, Inc. (“Xponential” or the “Company”) (NYSE: XPOF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-998
Hematological Disorders Pipeline Report 2023 – Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
DUBLIN, Jan. 22, 2024 /PRNewswire/ — The “Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update” report has been added to ResearchAndMarkets.com’s offering. The Medical Devices
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation – CTSO
NEW YORK, Jan. 22, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Cytosorbents Corporation (“Cytosorbents” or the “Company”) (NASDAQ: CTSO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. – MDXG
NEW YORK, Jan. 22, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQ: MDXG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Global Behavioral Biometrics Market Competitive Strategies and Forecasts, 2023- 2031: Market to Grow at a 27.1% CAGR from 2023 to 2031, Driven by Rising Security Demands and Technological Advancements
DUBLIN, Jan. 22, 2024 /PRNewswire/ — The “Global Behavioral Biometrics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031” report has been added to ResearchAndMarkets.com’s offer